YSB (HKG:9885) expects its H1 profit to rise more than three times year over year, according to a Hong Kong bourse filing Thursday.
Shares of the pharmaceutical retailer fell nearly 2% in recent Friday trade.
The company anticipates attributable profit of at least 70 million yuan for the six months ended June 30, compared to 21.8 million yuan in the year-ago period.
The company will likely post its results by the end of August.